We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Professor of Urology and Oncology, Johns Hopkins University, Baltimore, Maryland
Dr. Isaacs has worked in the area of prostate cancer biology and genetics for the past 25 years. His interests continue to be in the area of understanding mechanisms underlying inherited risk for prostate cancer and disease progression, both from the perspective of developing markers to identify men at high risk for targeted screening and identifying novel pathways that may be exploited for chemopreventive and therapeutic purposes. His most recent efforts are focused upon developing protocols for translating genetic information to clinically important decision-making processes in the screening and management of prostate cancer.